UWSpace is currently experiencing technical difficulties resulting from its recent migration to a new version of its software. These technical issues are not affecting the submission and browse features of the site. UWaterloo community members may continue submitting items to UWSpace. We apologize for the inconvenience, and are actively working to resolve these technical issues.
 

Evaluation and Comparison of Two Novel Non-Platinum-Based Antitumor Agents on Pancreatic Cancer and Triple-Negative Breast Cancer

dc.contributor.authorXu, Xiangxuan
dc.date.accessioned2022-10-03T12:35:20Z
dc.date.available2023-10-04T04:50:03Z
dc.date.issued2022-10-03
dc.date.submitted2022-09-20
dc.description.abstractCancer is one of the leading causes threatening human life. People suffering from pancreatic cancer and triple-negative breast cancer (TNBC) have particularly low survival rate among all cancer types. The novel non-platinum based antitumor agents, femtomedicine (FMD) compounds, were discovered as a new class of chemotherapeutic targeting agents to treat multiple cancers. Herein, two of the most effective FMD compounds (FMD-2Br-DAB & FMD-2I-DAB) were evaluated, based on their cytotoxicity against TNBC and pancreatic cancer cells through MTT assay, clonogenic assay, and caspase-3/7 green detection. According to the results obtained from these well-established cell-biology techniques, FMD compounds exhibit good antitumor effects in the cancer cell lines (PANC-1, BXPC-3, and MDA-MB-231), while having minimal impact on the normal cell line (GM05757), indicating FMD compounds can selectively kill TNBC and pancreatic cancer cells without being detrimental to normal cells. Furthermore, FMD-2I-DAB (compound C) shows a better efficiency than FMD-2Br-DAB (compound B), inferring that compound C could be more potent in tumor elimination. This study shows that the FMD compounds, especially for compound C, are potentially new drug candidates for effective treatment of the ‘hard-to-treat’ pancreatic cancer and TNBC.en
dc.identifier.urihttp://hdl.handle.net/10012/18864
dc.language.isoenen
dc.pendingfalse
dc.publisherUniversity of Waterlooen
dc.titleEvaluation and Comparison of Two Novel Non-Platinum-Based Antitumor Agents on Pancreatic Cancer and Triple-Negative Breast Canceren
dc.typeMaster Thesisen
uws-etd.degreeMaster of Scienceen
uws-etd.degree.departmentPhysics and Astronomyen
uws-etd.degree.disciplinePhysicsen
uws-etd.degree.grantorUniversity of Waterlooen
uws-etd.embargo.terms1 yearen
uws.contributor.advisorLu, Qing-Bin
uws.contributor.affiliation1Faculty of Scienceen
uws.peerReviewStatusUnrevieweden
uws.published.cityWaterlooen
uws.published.countryCanadaen
uws.published.provinceOntarioen
uws.scholarLevelGraduateen
uws.typeOfResourceTexten

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Xu_Xiangxuan.pdf
Size:
1.86 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
6.4 KB
Format:
Item-specific license agreed upon to submission
Description: